The Precise Sequence of FGF Receptor Autophosphorylation Is Kinetically Driven and Is Disrupted by Oncogenic Mutations

Sci. Signal., 17 February 2009
Vol. 2, Issue 58, p. ra6
DOI: 10.1126/scisignal.2000021

The Precise Sequence of FGF Receptor Autophosphorylation Is Kinetically Driven and Is Disrupted by Oncogenic Mutations

  1. Erin D. Lew*,
  2. Cristina M. Furdui,
  3. Karen S. Anderson, and
  4. Joseph Schlessinger
  1. Department of Pharmacology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA.
  1. To whom correspondence should be addressed. E-mail: joseph.schlessinger{at}
  • * Present address: Molecular Neurobiology Laboratory, The Salk Institute, 10010 N. Torrey Pines Road, La Jolla, CA 92037, USA.

  • Present address: Department of Internal Medicine, Section on Molecular Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.


Autophosphorylation of the tyrosine kinase domain of fibroblast growth factor receptor 1 (FGFR1) is mediated by a sequential and precisely ordered three-stage autophosphorylation reaction. First-stage autophosphorylation of an activation loop tyrosine leads to 50- to 100-fold stimulation of kinase activity and is followed by second-stage phosphorylation of three additional tyrosine residues, which are binding sites for signaling molecules. Finally, third-stage phosphorylation of a second activation loop tyrosine leads to an additional 10-fold stimulation of FGFR1 catalytic activity. In this report, we show that sequential autophosphorylation of five tyrosines in the FGFR1 kinase domain is under kinetic control, mediated by both the amino acid sequence surrounding the tyrosines and their locations within the kinase structure, and, moreover, that phosphoryl transfer is the rate-limiting step. Furthermore, the strict order of autophosphorylation is disrupted by a glioblastoma-derived, oncogenic FGFR1 point mutation in the kinase domain. We propose that disrupted stepwise activation of tyrosine autophosphorylation caused by oncogenic and other activating FGFR mutations may lead to aberrant activation of and assembly of signaling molecules by the activated receptor.


E. D. Lew, C. M. Furdui, K. S. Anderson, and J. Schlessinger, The Precise Sequence of FGF Receptor Autophosphorylation Is Kinetically Driven and Is Disrupted by Oncogenic Mutations. Sci. Signal. 2, ra6 (2009).

Differential Effects of Tyrosine Kinase Inhibitors on Normal and Oncogenic EGFR Signaling and Downstream Effectors
Y. Kim, M. Apetri, B. Luo, J. E. Settleman, and K. S. Anderson
Mol Cancer Res 13, 765-774 (1 April 2015)

Structure, domain organization, and different conformational states of stem cell factor-induced intact KIT dimers
Y. Opatowsky, I. Lax, F. Tome, F. Bleichert, V. M. Unger, and J. Schlessinger
Proc. Natl. Acad. Sci. USA 111, 1772-1777 (4 February 2014)

How IGF-1 activates its receptor
J. M. Kavran, J. M. McCabe, P. O. Byrne, M. K. Connacher, Z. Wang, A. Ramek, S. Sarabipour, Y. Shan, D. E. Shaw, K. Hristova et al.
elife 3, e03772-e03772 (1 January 2014)

FGFR1 mutations cause Hartsfield syndrome, the unique association of holoprosencephaly and ectrodactyly
N. Simonis, I. Migeotte, N. Lambert, C. Perazzolo, D. C. de Silva, B. Dimitrov, C. Heinrichs, S. Janssens, B. Kerr, G. Mortier et al.
J. Med. Genet. 50, 585-592 (1 September 2013)

ERK-Mediated Phosphorylation of Fibroblast Growth Factor Receptor 1 on Ser777 Inhibits Signaling
M. Zakrzewska, E. M. Haugsten, B. Nadratowska-Wesolowska, A. Oppelt, B. Hausott, Y. Jin, J. Otlewski, J. Wesche, and A. Wiedlocha
Sci Signal 6, ra11-ra11 (12 February 2013)

Grb2, a Double-Edged Sword of Receptor Tyrosine Kinase Signaling
A. A. Belov, and M. Mohammadi
Sci Signal 5, pe49-pe49 (6 November 2012)

Macrophage Proliferation Is Regulated through CSF-1 Receptor Tyrosines 544, 559, and 807
W. Yu, J. Chen, Y. Xiong, F. J. Pixley, Y.-G. Yeung, and E. R. Stanley
J Biol Chem 287, 13694-13704 (20 April 2012)

Distinct Involvement of the Gab1 and Grb2 Adaptor Proteins in Signal Transduction by the Related Receptor Tyrosine Kinases RON and MET
A. Chaudhuri, M.-H. Xie, B. Yang, K. Mahapatra, J. Liu, S. Marsters, S. Bodepudi, and A. Ashkenazi
J Biol Chem 286, 32762-32774 (16 September 2011)

A Novel Mode of Protein Kinase Inhibition Exploiting Hydrophobic Motifs of Autoinhibited Kinases: DISCOVERY OF ATP-INDEPENDENT INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR
S. Eathiraj, R. Palma, M. Hirschi, E. Volckova, E. Nakuci, J. Castro, C.-R. Chen, T. C. K. Chan, D. S. France, M. A. Ashwell et al.
J Biol Chem 286, 20677-20687 (10 June 2011)

A regression framework incorporating quantitative and negative interaction data improves quantitative prediction of PDZ domain-peptide interaction from primary sequence
X. Shao, C. S. H. Tan, C. Voss, S. S. C. Li, N. Deng, and G. D. Bader
Bioinformatics 27, 383-390 (1 February 2011)

Roles of Fibroblast Growth Factor Receptors in Carcinogenesis
E. M. Haugsten, A. Wiedlocha, S. Olsnes, and J. Wesche
Mol Cancer Res 8, 1439-1452 (1 November 2010)

Computational Tools for the Interactive Exploration of Proteomic and Structural Data
J. H. Morris, E. C. Meng, and T. E. Ferrin
MCP 9, 1703-1715 (1 August 2010)

Mammary Gland Growth Factors: Roles in Normal Development and in Cancer
N. E. Hynes, and C. J. Watson
Cold Spring Harb. Perspect. Biol. 2, a003186-a003186 (1 August 2010)

Signal Transducers and Activators of Transcription-3 Binding to the Fibroblast Growth Factor Receptor Is Activated by Receptor Amplification
A. A. Dudka, S. M. M. Sweet, and J. K. Heath
Cancer Res. 70, 3391-3401 (15 April 2010)

Asymmetric receptor contact is required for tyrosine autophosphorylation of fibroblast growth factor receptor in living cells
J. H. Bae, T. J. Boggon, F. Tome, V. Mandiyan, I. Lax, and J. Schlessinger
Proc. Natl. Acad. Sci. USA 107, 2866-2871 (16 February 2010)

Science Signaling Podcast: 03 March 2009
J. Schlessinger, and A. M. VanHook
Sci Signal 2, pc5-pc5 (3 March 2009)

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882